468 related articles for article (PubMed ID: 19464093)
1. Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease.
Frasch CE; Borrow R; Donnelly J
Vaccine; 2009 Jun; 27 Suppl 2():B112-6. PubMed ID: 19464093
[TBL] [Abstract][Full Text] [Related]
2. Meningococcal surrogates of protection--serum bactericidal antibody activity.
Borrow R; Balmer P; Miller E
Vaccine; 2005 Mar; 23(17-18):2222-7. PubMed ID: 15755600
[TBL] [Abstract][Full Text] [Related]
3. Serum bactericidal antibody assays - The role of complement in infection and immunity.
McIntosh ED; Bröker M; Wassil J; Welsch JA; Borrow R
Vaccine; 2015 Aug; 33(36):4414-21. PubMed ID: 26187262
[TBL] [Abstract][Full Text] [Related]
4. Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines.
Toropainen M; Saarinen L; Wedege E; Bolstad K; Mäkelä PH; Käyhty H
Vaccine; 2005 Sep; 23(40):4821-33. PubMed ID: 15970361
[TBL] [Abstract][Full Text] [Related]
5. Meningococcal Serogroup A, B, C, W, X, and Y Serum Bactericidal Antibody Assays.
Lucidarme J; Louth J; Townsend-Payne K; Borrow R
Methods Mol Biol; 2019; 1969():169-179. PubMed ID: 30877677
[TBL] [Abstract][Full Text] [Related]
6. Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.
Giuliani MM; Biolchi A; Serruto D; Ferlicca F; Vienken K; Oster P; Rappuoli R; Pizza M; Donnelly J
Vaccine; 2010 Jul; 28(31):5023-30. PubMed ID: 20493284
[TBL] [Abstract][Full Text] [Related]
7. Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease.
Granoff DM
Vaccine; 2009 Jun; 27 Suppl 2(Suppl 2):B117-25. PubMed ID: 19477054
[TBL] [Abstract][Full Text] [Related]
8. Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity.
Welsch JA; Moe GR; Rossi R; Adu-Bobie J; Rappuoli R; Granoff DM
J Infect Dis; 2003 Dec; 188(11):1730-40. PubMed ID: 14639545
[TBL] [Abstract][Full Text] [Related]
9. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E
Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
Perrett KP; Snape MD; Ford KJ; John TM; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ
Pediatr Infect Dis J; 2009 Mar; 28(3):186-93. PubMed ID: 19209097
[TBL] [Abstract][Full Text] [Related]
11. Response of steroid-treated former preterm infants to a single dose of meningococcal C conjugate vaccine.
Clarke P; Robinson MJ; Ahmad I; Bedford-Russell AR; Connell JE; Powell PJ; Heath PT
Vaccine; 2006 Apr; 24(16):3273-8. PubMed ID: 16472548
[TBL] [Abstract][Full Text] [Related]
12. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
[TBL] [Abstract][Full Text] [Related]
13. A large portion of meningococcal antigen typing system-negative meningococcal strains from spain is killed by sera from adolescents and infants immunized with 4CMenB.
Abad R; Biolchi A; Moschioni M; Giuliani MM; Pizza M; Vázquez JA
Clin Vaccine Immunol; 2015 Apr; 22(4):357-60. PubMed ID: 25630407
[TBL] [Abstract][Full Text] [Related]
14. Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.
Borrow R; Goldblatt D; Andrews N; Richmond P; Southern J; Miller E
J Infect Dis; 2001 Aug; 184(3):377-80. PubMed ID: 11443568
[TBL] [Abstract][Full Text] [Related]
15. A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease.
Su EL; Snape MD
Expert Rev Vaccines; 2011 May; 10(5):575-88. PubMed ID: 21604979
[TBL] [Abstract][Full Text] [Related]
16. Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies.
Li Y; Zhang Q; Winterbotham M; Mowe E; Gorringe A; Tang CM
Infect Immun; 2006 Nov; 74(11):6348-55. PubMed ID: 16966413
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity.
Plested JS; Welsch JA; Granoff DM
Clin Vaccine Immunol; 2009 Jun; 16(6):785-91. PubMed ID: 19339487
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.
Trotter C; Findlow J; Balmer P; Holland A; Barchha R; Hamer N; Andrews N; Miller E; Borrow R
Clin Vaccine Immunol; 2007 Jul; 14(7):863-8. PubMed ID: 17494636
[TBL] [Abstract][Full Text] [Related]
19. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
[TBL] [Abstract][Full Text] [Related]
20. Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac.
Caron F; Delbos V; Houivet E; Deghmane AE; Leroy JP; Hong E; Bénichou J; Taha MK
Vaccine; 2012 Jul; 30(34):5059-62. PubMed ID: 22658929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
